Corpus Intelligence IC Memo — COOK CHILDRENS MEDICAL CENTER 2026-04-26 04:05 UTC
IC Memo — COOK CHILDRENS MEDICAL CENTER
Investment Committee Memorandum | TX | 423 beds | Grade B | EBITDA uplift $110.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

COOK CHILDRENS MEDICAL CENTER

CCN 453300 | TARRANT, TX | 423 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

COOK CHILDRENS MEDICAL CENTER is a 423-bed large academic medical center in TARRANT, TX with $1.51B in net patient revenue and a 16.5% operating margin. The hospital serves a payer mix of 0.6% Medicare, 5.3% Medicaid, and 94.1% commercial.

Thesis: Platform Growth. Our ML models identify $110.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 16.5% to 23.9% (+736bps).

Net Revenue HCRIS$1.51B
Current EBITDA COMPUTED$249.1M
Operating Margin COMPUTED16.5%
Occupancy HCRIS57.3%
Revenue / Bed COMPUTED$3.6M
Net-to-Gross HCRIS48.9%
Distress Probability ML45.3%

2. Market Context & Competitive Position

583
TX Hospitals
-0.7%
State Median Margin
93
Comparable Hospitals

TX has 583 Medicare-certified hospitals with a median operating margin of -0.7%. The target's margin of 16.5% places it above the state median. Among 93 size-comparable peers (212-846 beds), the median margin is 4.5%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (212-846), prioritizing same-state peers. 93 hospitals in the comp set.

HospitalStateBedsRevenueMargin
COOK CHILDRENS MEDICAL CENTER (Target)TX423$1.51B16.5%
UT MD ANDERSON CANCER CENTERTX721$4.90B-0.8%
UT SOUTHWESTERN UNIVERSITY HOSTX737$2.28B-4.6%
SCOTT AND WHITE MEMORIAL HOSPITX616$1.85B-10.5%
CHILDRENS MEDICAL CENTER OF DATX377$1.56B10.3%
MEDICAL CITY DALLASTX819$1.33B49.7%
BAYLOR UNIVERSITY MEDICAL CTRTX800$1.26B0.4%
THE UNIVERSITY OF TEXAS MEDICATX819$1.19B-29.9%
CHI ST LUKES HEALTH BAYLOR MEDTX628$1.10B-9.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $110.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$31.6M+210bp18mo
Cost to Collect4.5%2.5%$30.1M+200bp12mo
Denial Rate Reduction12.0%6.5%$29.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$18.3M+122bp9mo
Clean Claim Rate88.0%96.0%$965K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$31.6M
Cost to Collect
$30.1M
Denial Rate Reduction
$29.8M
A/R Days Reduction
$18.3M
Clean Claim Rate
$965K
Total EBITDA Uplift$110.9M
Current EBITDA$249.1M
+ RCM Uplift+$110.9M
Pro Forma EBITDA$360.0M
Current Margin16.5%
Pro Forma Margin23.9%
WC Released (1x)$57.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$383.2M$2.75B7.18x48.3%
Base (11x exit)10.0x11.0x$383.2M$3.15B8.23x52.4%
Bull Case9.0x11.0x$344.8M$3.64B10.56x60.2%
Bull (12x exit)9.0x12.0x$344.8M$4.08B11.82x63.9%
Bear Case11.0x10.0x$421.5M$2.07B4.92x37.5%
Bear (11x exit)11.0x11.0x$421.5M$2.42B5.74x41.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 93 hospitals with 212-846 beds
  • Same-state prioritization (n=94)
  • Comp margins: P25=-9.5% / P50=4.5% / P75=14.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.